Canada - francese - Health Canada

abbvie corporation - nébivolol (chlorhydrate de nébivolol) - comprimé - 10mg - nébivolol (chlorhydrate de nébivolol) 10mg - beta-adrenergic blocking agents

Canada - francese - Health Canada

abbvie corporation - nébivolol (chlorhydrate de nébivolol) - comprimé - 20mg - nébivolol (chlorhydrate de nébivolol) 20mg - beta-adrenergic blocking agents

Belgio - francese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - chlorhydrate de nébivolol 5,45 mg - eq. nébivolol 5 mg - comprimé - nebivolol

Belgio - francese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - chlorhydrate de nébivolol 5,45 mg - eq. nébivolol 5 mg - comprimé - nebivolol

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - i) 8.8 mcg/0.2 ml: interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg. ii) 22 mcg / 0.5 ml: interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en stylo prérempli - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.06 mg. - multiple sklerose - biotechnologika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.1 mg. - multiple sklerose - biotechnologika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.02 mg. - multiple sklerose - biotechnologika